Dr. Marshanski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3333 Burnet Avenue
Cincinnati, OH 45229
Education & Training
Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 2022 - 2025
Tel Aviv University SacklerClass of 2021
Publications & Presentations
PubMed
- Different infliximab induction dosing regimens do not affect remission rates up to 1 year in children with Crohn's disease.Tal Marshanski, Eliana Fanous, Noa Tal, Tsachi T Perets, Manar Matar
Journal of Pediatric Gastroenterology and Nutrition. 2024-09-01 - 1 citationsComparison of Clinical Outcomes in Pediatric Patients with Ileocolonic Crohn Disease Treated with Infliximab Versus Adalimumab.Eliana Fanous, Tal Marshanski, Noa Tal, Manar Matar, Yael Weintraub
Journal of Pediatric Gastroenterology and Nutrition. 2023-09-01 - 13 citationsDirected evolution of therapeutic antibodies targeting glycosylation in cancerRon Amon, Ronit Rosenfeld, Shahar Perlmutter, Oliver C. Grant, Sharon Yehuda
Cancers. 2020-09-30
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
